Karyopharm to participate at the canaccord genuity horizons in oncology conference

Newton, mass. , april 7, 2022 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the company's senior management team will participate in a fireside chat at the canaccord genuity horizons in oncology conference.

KPTI Ratings Summary

KPTI Quant Ranking